Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$2.61 - $4.41 $652 - $1,102
250 New
250 $0
Q3 2021

Nov 05, 2021

SELL
$9.7 - $14.34 $2,425 - $3,585
-250 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$13.43 - $19.16 $3,357 - $4,790
250 New
250 $4,000
Q1 2021

May 24, 2021

SELL
$15.82 - $22.11 $3,955 - $5,527
-250 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$7.36 - $9.87 $1,840 - $2,467
250 New
250 $2,000
Q2 2018

Jul 27, 2018

SELL
$5.99 - $8.17 $1,725 - $2,352
-288 Closed
0 $0
Q2 2017

Aug 17, 2017

BUY
N/A
288
288 $3,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $526M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.